These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2242115)

  • 41. Escherichia coli thymidylate synthase expression protects human cells from the cytotoxic effects of 5-fluorodeoxyuridine more effectively than human thymidylate synthase overexpression.
    Parsels LA; Kowalski MP; Wagner LM; Parsels JD; Maley F; Maybaum J
    Cancer Gene Ther; 2000 Aug; 7(8):1179-87. PubMed ID: 10975679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.
    Spears CP; Gustavsson BG; Frösing R
    Invest New Drugs; 1989 Apr; 7(1):27-36. PubMed ID: 2500406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor cell responses to inhibition of thymidylate synthase.
    Moran RG; Keyomarsi K; Patel R
    Adv Exp Med Biol; 1988; 244():71-83. PubMed ID: 2977717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytostatic/cytotoxic effects of 5-fluorouridine nucleolipids on colon, hepatocellular, and renal carcinoma cells: in vitro identification of a potential cytotoxic multi-anticancer drug.
    Farhat A; Malecki E; Bonaterra GA; Röthlein D; Wolf M; Schmitt J; Rosemeyer H; Kinscherf R
    Chem Biodivers; 2014 Mar; 11(3):469-82. PubMed ID: 24634076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
    Morgan RG
    Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potentiation of 5-fluorouracil induced inhibition of thymidylate synthase in human colon tumors by leucovorin is dose dependent.
    Peters GJ; Hoekman K; van Groeningen CJ; van der Wilt CL; Smid K; Meijer S; Pinedo HM
    Adv Exp Med Biol; 1993; 338():613-6. PubMed ID: 8304192
    [No Abstract]   [Full Text] [Related]  

  • 47. Somatostatin analogue octreotide modulates metabolism and effects of 5-fluorouracil and 5-fluorouridine in human colon cancer spheroids.
    Chen TB; Huzak M; Macura S; Vuk-Pavlović S
    Cancer Lett; 1994 Oct; 86(1):41-51. PubMed ID: 7954353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of fluoropyrimidine metabolism in L1210 cells by L-alanosine.
    Heimer R; Goldberg D; Cadman E
    Biochem Pharmacol; 1983 Jan; 32(2):199-206. PubMed ID: 6870949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of fluoropyrimidine metabolism by chlorpromazine.
    Tseng A; Brooks M; Cadman E
    Biochem Biophys Res Commun; 1986 Jul; 138(2):1009-14. PubMed ID: 3741420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
    Houghton JA; Houghton PJ
    Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reductions in gamma-globin mRNA levels restricted to the cytoplasm of 5-fluorouridine treated K-562 human erythroleukemia cells.
    Heimer R; Sartorelli AC
    Cancer Commun; 1990; 2(1):45-53. PubMed ID: 2369550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological activity of 5'-substituted 5-fluoropyrimidine nucleosides.
    Ajmera S; Danenberg PV
    J Med Chem; 1982 Aug; 25(8):999-1002. PubMed ID: 7120290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in metabolism of 5-fluorouracil and 5-fluorouridine and regulation by glucosamine in human colon cancer multicell tumor spheroids.
    Chen TB; Bajzer Z; Macura S; Vuk-Pavlovic S
    NMR Biomed; 1999 May; 12(3):157-67. PubMed ID: 10414950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the mechanism of fluoropyrimidine cytotoxicity in l1210 cells: correlation with inhibition of thymidylate synthetase but not with incorporation into RNA.
    Danenberg KD; Becker D; Mulkins MA; Danenberg PV
    Pharm Res; 1984 May; 1(3):110-5. PubMed ID: 24277246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic analysis of 5-fluorouracil action against various cancer cells.
    Inaba M; Mitsuhashi J; Ozawa S
    Jpn J Cancer Res; 1990 Oct; 81(10):1039-44. PubMed ID: 2146239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoropyrimidine-mediated changes in small nuclear RNA.
    Armstrong RD; Takimoto CH; Cadman EC
    J Biol Chem; 1986 Jan; 261(1):21-4. PubMed ID: 3941072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of 5-fluorouridine nucleolipid derivatives and their cytostatic/cytotoxic activities on human HT-29 colon carcinoma cells.
    Malecki E; Farhat A; Bonaterra GA; Röthlein D; Wolf M; Schmitt J; Kinscherf R; Rosemeyer H
    Chem Biodivers; 2013 Dec; 10(12):2235-46. PubMed ID: 24327444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RP-LC determination of 5-fluorouridine in nanoparticulate formulations.
    Arbós P; Campanero MA; Irache JM
    J Pharm Biomed Anal; 2002 Jun; 28(5):857-66. PubMed ID: 12039627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators.
    Weckbecker G
    Pharmacol Ther; 1991; 50(3):367-424. PubMed ID: 1721719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium leucovorin and 5-fluorouridine cytotoxicity.
    Berger SH; Hakala MT
    J S C Med Assoc; 1990 May; 86(5):284-9. PubMed ID: 2242115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.